证券日报网讯 12月10日晚间，合康新能发布公告称，公司于2025年12月10日召开第六届董事会第二十 五次会议审议通过了《关于续聘中审众环会计师事务所（特殊普通合伙）为公司2025年度审计机构的议 案》，拟继续聘请中审众环会计师事务所（特殊普通合伙）为公司2025年度财务及内控审计机构，聘期 一年。续聘事项尚需提交公司股东会审议。 （文章来源：证券日报） ...

登录新浪财经APP 搜索【信披】查看更多考评等级 北京安博通科技股份有限公司 关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 股东大会召开日期：2025年12月22日 2025年第二次临时股东大会 召开日期时间：2025年12月22日 14点30分 证券代码：688168 证券简称：安博通 公告编号：2025-043 召开地点：北京海淀区西北旺东路十号院15号楼A301会议室 （五）网络投票的系统、起止日期和投票时间。 无 二、会议审议事项 ● 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票系统 一、召开会议的基本情况 （一）股东大会类型和届次 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025年12月22日 至2025年12月22日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东大会召开当日的交易时间 段，即9:15-9:25，9:30-11:30，13:00-15:00；通过互联网投票平台的投 ...

Group 1 - The company held its 22nd meeting of the 9th Board of Directors on December 2, 2025, with all 9 directors present, and the meeting was conducted in accordance with legal and regulatory requirements [2] - The Board approved the proposal to appoint Tianzhi International Accounting Firm for the 2025 financial and internal control audits with unanimous consent [3] - The proposal to convene the 5th extraordinary general meeting of shareholders in 2025 was also approved unanimously [3] Group 2 - Tianzhi International Accounting Firm, established in December 1988, is a large comprehensive consulting firm based in Beijing, specializing in audit, capital market services, and management consulting [7] - For the year 2024, Tianzhi reported total audited revenue of 2.501 billion yuan, with audit service revenue of 1.938 billion yuan and securities service revenue of 912 million yuan [8] - The firm has a strong investor protection capability, having accumulated a professional risk fund and insurance coverage of no less than 200 million yuan [9] Group 3 - The proposed audit fees for 2025 are set at 1.8 million yuan for financial audits and 400,000 yuan for internal control audits, totaling 2.2 million yuan, unchanged from the previous year [14] - The audit committee reviewed Tianzhi's qualifications and recommended its reappointment, confirming the firm's capability to meet the company's audit requirements [15] - The reappointment of the accounting firm will be submitted for approval at the upcoming extraordinary general meeting of shareholders [16] Group 4 - The company announced that its controlling shareholder, Mingcheng Holdings Group, holds 39.81% of the company's shares, with 115,789,304 shares frozen and 119,798,179 shares marked by judicial authorities [19] - The total amount involved in the judicial actions is approximately 1.230 billion yuan [20] - The company assures that these legal issues will not adversely affect its operations or governance [20] Group 5 - The 5th extraordinary general meeting of shareholders is scheduled for December 22, 2025, with both on-site and online voting options available [23] - The meeting will be held at the Shanghai Millennium Seagull Hotel, and shareholders must register to attend [24] - Voting procedures and requirements for shareholders with multiple accounts are outlined to ensure proper representation [28]

证券代码：300560 证券简称：中富通 公告编号：2025-058 中富通集团股份有限公司第五届 登录新浪财经APP 搜索【信披】查看更多考评等级 本次会议经过认真审议并通过如下决议： （一）审议通过《关于增加公司经营范围的议案》，表决结果：9票同意、0票反对、0票弃权。 董事会第十二次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 2025年11月17日，中富通集团股份有限公司（以下简称"公司"）董事会以电子邮件、电话等形式向各位 董事发出召开公司第五届董事会第十二次会议的通知，并于2025年11月28日以现场和通讯相结合的方式 召开了此次会议。会议应到董事9人(其中独立董事3名)，实到9人，会议由董事长陈融洁先生主持。公 司监事及高级管理人员列席了此次会议。会议的召集和召开程序符合《中华人民共和国公司法》（以下 简称"《公司法》"）和《中富通集团股份有限公司章程》（以下简称"《公司章程》"）的有关规定。 二、董事会会议审议情况 根据业务发展及经营需要，公司拟增加经营范围。在原经营范围中增加"职业中介活动、教育咨询服 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000766 证券简称：通化金马 公告编号：2025-40 通化金马药业集团股份有限公司 第十一届董事会2025年第九次临时会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 1.通化金马药业集团股份有限公司第十一届董事会2025年第九次临时会议通知于2025年11月11日以微信 和电子邮件形式送达全体董事。 2.2025年11月12日上午9时30分以现场和通讯方式召开。 3.会议应到董事9人，实到董事9人。 4.会议由董事长张玉富先生主持，部分高管人员列席了本次会议。 5.本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文件和公司章程的规定。 二、董事会会议审议情况 1、审议并通过《关于续聘公司 2025 年度审计机构的议案》 经审议，同意续聘北京德皓国际会计师事务所（特殊普通合伙）担任公司 2025年度审计机构，负责公 司2025年度财务审计及内部控制审计等工作。详见同日公司在巨潮资讯网披露的《关于拟续聘会计师事 务所的公告》。 本议案已经董事会审计委 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002880 证券简称:卫光生物 公告编号:2025-047 深圳市卫光生物制品股份有限公司 第四届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 深圳市卫光生物制品股份有限公司（以下简称公司）第四届董事会第五次会议于2025年11月11日，在公 司办公楼四楼会议室以现场结合通讯的方式召开。本次会议应参加董事9名，实际参加董事9名，公司高 级管理人员列席了会议。本次会议由董事长张战先生主持，会议的召集、召开和表决程序符合《公司 法》等有关法律、法规及《公司章程》的规定。 二、董事会会议审议情况 会议经逐项审议，书面表决，审议通过了以下议案： 1.审议通过了《关于聘任董事会秘书的议案》; 本议案经提名委员会审议通过后，提交董事会审议。 董事会经审议同意聘任刘雪芬女士担任公司董事会秘书，任期自本次董事会审议通过之日起至第四届董 事会届满之日止。具体内容详见同日刊登在指定信息披露媒体及巨潮资讯网(www.cninfo.com.cn)的《关 于变更董事会秘书的 ...

Meeting Overview - The first extraordinary general meeting of shareholders for 2025 was held on November 11, 2025, at 14:30 [4][8] - The meeting combined on-site voting and online voting, with online voting available from 9:15 to 15:00 on the same day [5][4] - A total of 152 shareholders and authorized representatives attended, representing 163,911,202 shares, which is 42.5331% of the total voting shares [9] Voting Results - The proposal to reappoint the auditing firm for the 2025 fiscal year was approved with 99.9100% of votes in favor [13] - The proposal to amend the company's articles of association was also approved with 99.9078% of votes in favor [14] - Multiple governance proposals were passed, including amendments to the rules for shareholder meetings and board meetings, with approval rates exceeding 99% for most [16][19][21][23][28][30][32][35][38] Changes in Governance Structure - The company will no longer have a supervisory board, as approved in the extraordinary general meeting [43] - Three supervisors were relieved of their duties, with one continuing in another role within the company [43] - A new employee representative director, Ms. Lü Ronghua, was elected to the board, ensuring compliance with regulations regarding board composition [43][44] Legal Compliance - The legal opinion provided by Guangdong Guangxin Junda Law Firm confirmed that the meeting's procedures and resolutions were in accordance with relevant laws and the company's articles of association [40]

Core Viewpoint - The company has disclosed its third-quarter financial report for 2025, including details on asset impairment provisions and the appointment of an auditing firm for the upcoming year [9][29][32]. Financial Data - The company reported a total asset impairment provision of 17.19 million yuan for the first three quarters of 2025, with 4.58 million yuan in asset write-offs [29][30]. - The write-off of inventory amounted to 4.58 million yuan, with the original value being 5.20 million yuan and recovery at 0.62 million yuan [30]. Shareholder and Board Meetings - The sixth board meeting was held on October 24, 2025, where the third-quarter report was approved with unanimous consent from all attending directors [9][10]. - The sixth supervisory board meeting also approved the third-quarter report with full agreement from all attending supervisors [24][25]. Auditing Firm Appointment - The company plans to reappoint ShineWing Certified Public Accountants (Special General Partnership) as its auditing firm for the year 2025, pending approval from the shareholders' meeting [32][33]. - The auditing firm has a strong track record, with a total revenue of 4.05 billion yuan in 2024, including 2.59 billion yuan from auditing services [35][36]. Asset Impairment and Write-off Details - The company has conducted a comprehensive review of its assets for impairment signs, leading to the recognition of impairment provisions based on expected credit losses [29][30]. - The total impact of the impairment provisions and asset write-offs on the company's consolidated profit for the first three quarters of 2025 is a reduction of 17.09 million yuan [30].

Core Viewpoint - The company has announced its decision to provision for asset impairment for the first three quarters of 2025, amounting to a total of 9,990,402.60 yuan, to accurately reflect its financial status and asset conditions [8][12][63]. Financial Data - The company plans to provision for credit impairment losses of 11,084,952.89 yuan and asset impairment losses of -1,094,550.29 yuan, totaling 9,990,402.60 yuan for the first three quarters of 2025 [9][12]. - The impairment provisions will reduce the company's total profit for the first three quarters of 2025 by the same amount [12][21]. Shareholder Information - The company intends to repurchase its shares using a total fund of no less than 20 million yuan and no more than 40 million yuan, with a maximum repurchase price of 8.57 yuan per share [4][5]. Audit and Compliance - The company has not audited its third-quarter financial report for 2025 [7]. - The company has proposed to renew its contract with Tianzhi International Accounting Firm for the 2025 audit, which requires approval from the shareholders' meeting [24][66]. Governance Changes - The company plans to amend its articles of association to increase the board of directors from 7 to 8 members and eliminate the supervisory board, transferring its responsibilities to the audit committee [50][70].

Core Points - The company has announced the proposal to repurchase its shares, with a total amount not less than RMB 20 million and not exceeding RMB 40 million, at a maximum price of RMB 8.57 per share [4][5] - The company plans to appoint Tianzhi International Accounting Firm as its auditor for the year 2025, which has extensive experience in providing audit services to listed companies [8][9] - The company has decided to provision for asset impairment totaling RMB 9,990,402.60 for the first three quarters of 2025, reflecting a cautious approach to its financial reporting [22][24] Financial Data - The company reported a total of RMB 9,990,402.60 in asset impairment provisions for the first three quarters of 2025, including RMB 11,084,952.89 for credit impairment losses [23][25] - The maximum repurchase price for shares will be adjusted to RMB 8.47 per share after the annual equity distribution [5] - The company has repurchased a total of 1,550,000 shares, accounting for 0.40% of the total share capital, with a total payment of RMB 8,996,100 [5] Shareholder Information - The company will hold a temporary shareholders' meeting to approve the proposed share repurchase and the appointment of the auditing firm [19][69] - The board of directors and the supervisory board have approved the asset impairment provisions, confirming compliance with accounting standards [34][42] Governance Changes - The company plans to amend its articles of association to increase the board size from 7 to 8 members and eliminate the supervisory board, transferring its responsibilities to the audit committee [70][72] - The company has revised several internal governance rules to enhance its governance structure [73]